mass spectrometry

Detecting tumor antigens is key to developing effective cancer diagnostics, immunotherapies, and vaccines.

Achieving higher accuracy and depth in bottom-up proteomics involves navigating a multifaceted process with various steps and challenges.

An ingenious chemical labeling strategy offers solutions to enhancing throughput in mass spectrometry analysis.

Scientists coupled mass spectrometry imaging with spatial transcriptomics in a single tissue, allowing for new discoveries in rare samples.

Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery. 

LIVE September 13th, 2021 at 11:00 AM ET
In this webinar, Shane Needham will discuss methods to optimize protein quantification workflows and introduce a new HRAMS system, the ZenoTOF 7600.   

Quantifying biotherapeutics in biological matrices plays a critical role in the drug discovery and development process. Ligand binding assays often lack the sensitivity to detect low-concentration analytes, particularly with limited sample supply.  

Purdue researchers apply machine learning concepts to create a new mass spec method